KALARIS THERAPEUTICS, INC. (KLRS) Shareholders’ equity
KALARIS THERAPEUTICS, INC. (KLRS) shareholders’ equity at each fiscal year-end, per SEC filings.
-$51.5MFY2020
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$51.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice